Inside the FDA Under Trump 2.0 Transition: What We Know & What to Expect From a Career FDA Attorney

Join us for a discussion on what’s happening at the Food and Drug Administration (FDA) during the Trump administration transition and what you can expect moving forward. Joy Sharp, a career FDA regulatory attorney who was at the agency during the Trump 1.0 transition, will share her experience and insights into what’s likely happening within the FDA, including the Office of the Commissioner; the policy, enforcement and executive management divisions of the drug, device and food product centers; as well as the Office of Inspections and Investigations (previously Office of Regulatory Affairs). The Department of Government Efficiency, Health and Human Services, and National Institutes of Health will also be discussed. Learn what to expect moving forward as the FDA adapts to new leadership and policies.

Time

12:00-1:00 p.m. ET

Have a scheduling conflict? Register for the live event and we’ll send you the on-demand recording shortly after the broadcast date. Content is available to view on demand through Tuesday, May 13, 2025. Please note, continuing education credit is not available for on-demand viewing.